No Data
Touyun Biotech Schedules Key Financial Meeting
Touyun Biotech (01332.HK) plans to hold a board of directors meeting on August 23 to approve the mid-term performance.
Touyun Biotech (01332.HK) announced that the board of directors meeting will be held on August 23, 2024 (Friday), to approve the publication of the interim performance announcement of the company and its subsidiaries for the six months ended June 30, 2024, and consider the distribution of interim dividends.
China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders
TOUYUN BIOTECH: Annual Report 2023
Touyun Biotech Group Limited's (HKG:1332) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Touyun Biotech (01332) released annual results, losses attributable to shareholders of 269 million yuan, an increase of 35.78% year-on-year
According to the Zhitong Finance App, Touyun Biotech (01332) announced its annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share. According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.
Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 49%No Data
